Why Vertex Lost in November

Although Vertex (Nasdaq: VRTX  ) is still up 20% for the year as a whole, it dropped by about a fifth of its share price in November. The stock has been hit twofold. Results keep pouring in from both Abbott Labs' (NYSE: ABT  ) and Gilead's (Nasdaq: GILD  ) next generation hepatitis-C drug cocktails, with tremendous cure rates and without requiring the use of interferon -- you start to see the problem for Vertex's Incivek. Furthermore, quarterly results had sales of its cystic fibrosis drug coming in light of estimates, but international expansion should accelerate its growth. Watch and find out what David Williamson thinks about Vertex's month and what the future holds for the stock.

With the impending spinoff of its branded-drug business, Abbott Labs is losing a massive blockbuster drug in Humira. It's a confusing event to understand, with many investors left wondering what to do with these two stocks once they're separated. To help investors better understand the upcoming event, the Fool has created a brand new premium report outlining both Abbott Labs and its spinoff, AbbVie. Inside, we outline all of the must-know opportunities and risks facing both companies, so make sure to claim this 2-for-1 report by clicking here now

Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2139222, ~/Articles/ArticleHandler.aspx, 10/27/2016 11:27:08 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,201.59 2.26 0.01%
S&P 500 2,136.53 -2.90 -0.14%
NASD 5,236.57 -13.70 -0.26%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/27/2016 11:11 AM
VRTX $78.40 Down -0.31 -0.39%
Vertex Pharmaceuti… CAPS Rating: ****
ABT $40.38 Up +0.42 +1.04%
Abbott Laboratorie… CAPS Rating: *****
GILD $75.96 Up +0.58 +0.77%
Gilead Sciences CAPS Rating: *****